期刊文献+

特苏尼治疗胸、腹腔积液32例临床观察 被引量:1

下载PDF
导出
摘要 目的探讨胸腔积液、腹腔积液对症治疗方法。方法32例胸腔积液、腹腔积液应用特苏尼治疗10天,监测血生化、肝功能、肾功能及胸腔、腹腔彩色超声,记录KPS评分。结果应用特苏尼后胸腔、腹腔彩色超声显示最大液平面深度减少,而血生化、尤其血钾未降低,肝功能、肾功能变化小,KPS评分增加。结论特苏尼可减轻胸腔、腹腔积液,患者憋气及腹胀症状减轻,生活质量提高,不产生电解质紊乱,对肝功能、肾功能影响小。
出处 《江苏药学与临床研究》 2005年第6期34-35,共2页 Jiangsu Pharmacertical and Clinical Research
  • 相关文献

参考文献7

  • 1王庆华.恶性肿瘤化疗方案规范[M].辽宁:科学技术出版社,2002.14.
  • 2Masereel B,Ferrari P,Ferrandi,et al.Na^+,2Cl^-,K^+ contransport system as a marker of antihypertensive activity of new torasemide derivatives[J].Eur J Pharmacol,1992,219(3):385~394.
  • 3Herchuelz A,Deger F,Douchamps J,et al.Comparative pharmacodynamics of torasemide and furosemide in patients with oedema[J].Arzneimittelforschung,1988,38(1A):180~183.
  • 4Friedel HA,Buckley MM.Torasemide:A review of its pharmacological properties and therapeutic potential[J].Drugs,1991,41(1):81~103.
  • 5Risler T,Kramer B,Muller GA.The efficacy of diuretics in acute and chronic renal failure[J].Drugs,1991,41(13):69~79.
  • 6Fiaccadori F,Pastti GC,Pedretti G,et al.Comparative analysis of torasemide and furosemide in liver cirrhosis[J].Cardiology,1994:84(12):S80~S86.
  • 7Krankenhaus der Barmherzigen Bruder,Nephrology Trier,et al.High-dose torasemide,given once daily intraveniously for one week,in patients with advanced chronic renal failure[J].Clin Nephrol,1997,48(1):22~28.

共引文献1

同被引文献6

  • 1邹建洲,滕杰,丁小强,吉俊,王吉耀,李志善,陈楠,袁耀宗,戚文航,顾勇,卢洪洲,蒋文斌,范维琥.托拉塞米注射液治疗水肿性疾病安全性和利尿效果研究[J].中华肾脏病杂志,2005,21(2):95-97. 被引量:38
  • 2林桂珍,林国生,郑民安,韩斌.观察托拉塞米短期治疗充血性心力衰竭的疗效及对B型钠尿肽的影响[J].江苏药学与临床研究,2006,14(1):40-42. 被引量:7
  • 3Ishido H, Senzaki H. Torasemide for the treatment of heart failure [J]. Cardiovascular&Hematological Disorders Drag Targets,2008, 8(2) :127 - 132.
  • 4Preobrazhenskii DV,Sidorenko BA,Tarykina EV, et al. Torasemide - new generation loop diuretic : clinical pharma - cology and thera- peutic applieation[J]. Kardiologiia,2006,46(10) :75 -86.
  • 5Kasama S, Toyama T, Hatori T, et al. Effects of torasemide on car- diac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure [ J ]. Heart, 2006,92 ( 10 ) : 1434 - 1440.
  • 6Lopez B, Gonzalez A, Beaumont J, et al. Identification of a potential cardiac antifibrotic mechanism of torasmide in patients with chronic heart failure [ J ]. J Am coll Cardiol,2007,50 ( 9 ) :67 - 859.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部